Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Ischemia

dabigatran has been researched along with Ischemia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (63.64)24.3611
2020's4 (36.36)2.80

Authors

AuthorsStudies
Murray, KT; Ray, WA1
Gu, HQ1
Barco, S; Barosi, G; Di Pilla, M; Lodigiani, C; Sacco, C1
Fujii, T; Gyoten, K; Hayasaki, A; Hibi, T; Iizawa, Y; Kishiwada, M; Kuriyama, N; Maeda, K; Mizuno, S; Murata, Y; Noguchi, D; Sakurai, H; Shinkai, T; Tanemura, A1
Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N1
Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M1
Bender, M1
Ahrens, I; Bode, C1
Baber, U; Mastoris, I; Mehran, R1
Acin, F; Bleda, S; Cañibano, C; De Haro, J; Varela, C1
Alonso de Leciñana, M; Aparicio, M; Buisan, J; García-Caldentey, J; Guillán, M; Masjuan, J; Matute, MC1

Reviews

3 review(s) available for dabigatran and Ischemia

ArticleYear
Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis - case report and systematic review of dabigatran use.
    VASA. Zeitschrift fur Gefasskrankheiten, 2021, Volume: 50, Issue:2

    Topics: Anticoagulants; Dabigatran; Heparin; Humans; Ischemia; Male; Middle Aged; Primary Myelofibrosis; Thrombocytopenia; Thrombosis

2021
Balancing ischaemia and bleeding risks with novel oral anticoagulants.
    Nature reviews. Cardiology, 2014, Volume: 11, Issue:12

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Ischemia; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism

2014
Meta-analysis and adjusted indirect comparison of direct oral anticoagulants in prevention of acute limb ischemia in patients with atrial fibrillation.
    Current medical research and opinion, 2016, Volume: 32, Issue:6

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Humans; Ischemia; Leg; Odds Ratio; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin

2016

Other Studies

8 other study(ies) available for dabigatran and Ischemia

ArticleYear
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reply.
    JAMA, 2022, 04-05, Volume: 327, Issue:13

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Pyrazoles; Pyridones; Rivaroxaban; Stroke

2022
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.
    JAMA, 2022, 04-05, Volume: 327, Issue:13

    Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Ischemia; Pyrazoles; Pyridones; Rivaroxaban; Stroke

2022
The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021, Volume: 27, Issue:3

    Topics: Animals; Dabigatran; Endothelial Cells; Hepatocytes; Humans; Ischemia; Liver; Liver Transplantation; Mice; Reperfusion Injury

2021
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:3

    Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K

2018
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:1

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood-Brain Barrier; Cerebral Arteries; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Rats; Stroke; Thrombolytic Therapy; Warfarin

2013
Dabigatran has the upper hand on warfarin.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:1

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Ischemia; Stroke; Thrombolytic Therapy

2013
Direct oral anticoagulants in acute coronary syndrome.
    Seminars in hematology, 2014, Volume: 51, Issue:2

    Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Humans; Ischemia; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes

2014
Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:1

    Topics: Aged; Antithrombins; Aphasia; Benzimidazoles; beta-Alanine; Carotid Artery Diseases; Dabigatran; Female; Fracture Fixation; Hemiplegia; Hemorrhage; Humans; Ischemia; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Failure; Risk; Stroke; Thrombolytic Therapy; Thrombosis

2011